Original Research
21 February 2012

The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007

Publication: Annals of Internal Medicine
Volume 156, Number 4

Abstract

This article has been corrected. The original version (PDF) is appended to this article as a supplement.

Background:

The increasing health burden and mortality from hepatitis B virus (HBV) and hepatitis C virus (HCV) in the United States are underappreciated.

Objective:

To examine mortality from HBV; HCV; and, for comparison, HIV.

Design:

Analysis of U.S. multiple-cause mortality data from 1999 to 2007 from the National Center for Health Statistics.

Setting:

All U.S. states and the District of Columbia.

Participants:

Approximately 22 million decedents.

Measurements:

Age-adjusted mortality rates from HBV, HCV, and HIV. Logistic regression analyses of 2007 data generated 4 independent models per outcome (HCV- or HBV-related deaths) that each included 1 of 4 comorbid conditions and all sociodemographic characteristics.

Results:

Between 1999 and 2007, recorded deaths from HCV increased significantly to 15 106, whereas deaths from HIV declined to 12 734 by 2007. Factors associated with HCV-related deaths included chronic liver disease, HBV co-infection, alcohol-related conditions, minority status, and HIV co-infection. Factors that increased odds of HBV-related death included chronic liver disease, HCV co-infection, Asian or Pacific Islander descent, HIV co-infection, and alcohol-related conditions. Most deaths from HBV and HCV occurred in middle-aged persons.

Limitation:

A person other than the primary physician of the decedent frequently completed the death certificate, and HCV and HBV often were not detected and thus not reported as causes of death.

Conclusion:

By 2007, HCV had superseded HIV as a cause of death in the United States, and deaths from HCV and HBV disproportionately occurred in middle-aged persons. To achieve decreases in mortality similar to those seen with HIV requires new policy initiatives to detect patients with chronic hepatitis and link them to care and treatment.

Primary Funding Source:

Centers for Disease Control and Prevention.

Get full access to this article

View all available purchase options and get full access to this article.

Supplemental Material

Original Version (PDF)

References

1.
Xu JKochanek KDMurphy SLTejada-Vera B. Deaths: final data for 2007. Natl Vit Stat Rep. 2010;58:1-136.
2.
American Cancer Society. Cancer Facts and Figure 2010. Atlanta: American Cancer Soc; 2010. Accessed at www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-026238.pdf on 9 December 2011.
3.
El-Serag HB. Epidemiology of hepatocellular carcinoma in USA. Hepatol Res. 2007;37 Suppl 2 S88-94. [PMID: 17877502]
4.
Everhart JE. Viral hepatitis. In: Everhart JE, eds. The Burden of Digestive Diseases in the United States. Washington, DC: U.S. Government Printing Office; 2008.
5.
Wise MBialek SFinelli LBell BPSorvillo F. Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology. 2008;47:1128-35. [PMID: 18318441]
6.
Wong JBMcQuillan GMMcHutchison JGPoynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health. 2000;90:1562-9. [PMID: 11029989]
7.
Centers for Disease Control and Prevention. Viral Hepatitis Surveillance—United States, 2009. Accessed at www.cdc.gov/hepatitis/Statistics/2009Surveillance/PDFs/2009HepSurveillanceRpt.pdf on 9 December 2011.
8.
Wasley AKruszon-Moran DKuhnert WSimard EPFinelli LMcQuillan Get al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis. 2010;202:192-201. [PMID: 20533878]
9.
Weinbaum CMWilliams IMast EEWang SAFinelli LWasley Aet alCenters for Disease Control and Prevention (CDC). Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57 (RR-8) 1-20. [PMID: 18802412]
10.
Armstrong GLWasley ASimard EPMcQuillan GMKuhnert WLAlter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705-14. [PMID: 16702586]
11.
National Center for Health Statistic. U.S. Standard Death Certificate. Hyattsville, MD: Centers for Disease Control and Prevention; 2003.
12.
National Center for Health Statistic. Physicians' Handbook on Certification of Death, 2003 Revision. DHHS publication no. (PHS) 2003-1108. Hyattsville, MD: Centers for Disease Control and Prevention; 2003.
13.
World Health Organizatio. International Classification of Diseases, 10th Revision. Geneva: World Health Organization; 1998.
14.
Institute for Social Research, University of Michigan. Coded Causes of Death. Ann Arbor: Univ Michigan; 2011. Accessed at simba.isr.umich.edu/restricted/docs/Mortality/codedcauses_readfirst.pdf on 9 December 2011.
15.
National Center for Health Statistics. Public Use Data Set Documentation: Mortality for ICD-10, 1999. Hyattsville, MD: Centers for Disease Control and Prevention. Accessed at www.cdc.gov/nchs/data/dvs/Mort99doc.pdf on 9 December 2011.
16.
Klein RJSchoenborn CA. Age adjustment using the 2000 projected U.S. population. Healthy People 2010 Stat Notes. 2001;:1-10.
17.
Vogt TMWise MEShih HWilliams IT. Final Program and Abstracts of the 45th Annual Meeting of the Infectious Diseases Society of America. Arlington, VA: Infectious Diseases Soc of America; 2007:172.
18.
Rein DBWittenborn JSWeinbaum CMSabin MSmith BDLesesne SB. Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States. Dig Liver Dis. 2011;43:66-72. [PMID: 20739252]
19.
Koh HK. Viral hepatitis: confronting a silent epidemic. President's Choice Lecture. Presented at the American Association for the Study of Liver Diseases 61st Liver Meeting, Boston, Massachusetts, 31 October 2010.
20.
Spradling P, Rupp L, Moorman A, Lu M, Teshale E, Gordon S, et al. Predictors of testing for and infection with hepatitis B virus (HBV) and hepatitis C virus (HCV) in four United States Health Care Organizations (HCOs), 2006-2008 [Abstract]. Presented at 49th Annual Meeting of the Infectious Diseases Society of America, Boston, Massachusetts, 20–23 October 2011.
21.
Cohen CHolmberg SDMcMahon BJBlock JMBrosgart CLGish RGet al. Is chronic hepatitis B being undertreated in the United States? J Viral Hepat. 2011;18:377-83. [PMID: 21143343]
22.
Denniston MM, Klevens RM, McQuillan GM, Jiles RB. Awareness of infection, knowledge of hepatitis C and medical follow-up among individuals testing positive for hepatitis C: NHANES 2001-2008. Hepatol. 2012. [Forthcoming].
23.
Campsmith MLRhodes PHHall HIGreen TA. Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J Acquir Immune Defic Syndr. 2010;53:619-24. [PMID: 19838124]
24.
Colvin HMMitchell AEInstitute of Medicine. Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. Washington, DC: National Academies Pr; 2010.
25.
Seeff LB. The natural history of chronic hepatitis C virus infection. Clin Liver Dis. 1997;1:587-602. [PMID: 15560060]
26.
Thomas DLSeeff LB. Natural history of hepatitis C. Clin Liver Dis. 2005;9:383-98, vi. [PMID: 16023972]
27.
Hahn RAWetterhall SFGay GAHarshbarger DSBurnett CAParrish RGet al. The recording of demographic information on death certificates: a national survey of funeral directors. Public Health Rep. 2002;117:37-43. [PMID: 12297680]
28.
Murray CJRajaratnam JKMarcus JLaakso TLopez AD. What can we conclude from death registration? Improved methods for evaluating completeness. PLoS Med. 2010;7:1000262. [PMID: 20405002]
29.
Adih WKSelik RMXiaohong Hu. Trends in diseases reported on US death certificates that mentioned HIV infection, 1996-2006. J Int Assoc Physicians AIDS Care (Chic). 2011;10:5-11. [PMID: 21088284]
30.
Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep. 1998;47(RR-19):1-39. [ 9790221]
31.
Shehab TMOrrego MChunduri RLok AS. Identification and management of hepatitis C patients in primary care clinics. Am J Gastroenterol. 2003;98:639-44. [PMID: 12650800]
32.
Kallman JBArsalla APark VDhungel SBhatia PHaddad Det al. Screening for hepatitis B, C and non-alcoholic fatty liver disease: a survey of community-based physicians. Aliment Pharmacol Ther. 2009;29:1019-24. [PMID: 19220207]
33.
O'Brien SFXi GYi QLGoldman M. Understanding non-disclosure of deferrable risk: a study of blood donors with a history of intravenous drug use. Transfus Med. 2010;20:15-21. [PMID: 19793079]
34.
El-Kamary SSJhaveri RShardell MD. All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population. Clin Infect Dis. 2011;53:150-7. [PMID: 21665867]
35.
Manos MMLeyden WAMurphy RCTerrault Bell BP. Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment. Hepatology. 2008;47:1150-7. [PMID: 18264998]
36.
Selik RMAnderson RNMcKenna MTRosenberg HM. Increase in deaths caused by HIV infection due to changes in rules for selecting underlying cause of death. J Acquir Immune Defic Syndr. 2003;32:62-9. [PMID: 12514415]
37.
National Center for Health Statistics. Instructions for Classifying the Underlying Cause of Death, ICD-10, 2010. Accessed at www.cdc.gov/nchs/data/dvs/2A_2010acc.pdf on 4 April 2011.
38.
Palella FJ JrBaker RKMoorman ACChmiel JSWood KCBrooks JTet alHIV Outpatient Study Investigators. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43:27-34. [PMID: 16878047]
39.
U.S. Department of Health and Human Services. Combating the Silent Epidemic of Viral Hepatitis: Action Plan for the Prevention, Care and Treatment of Viral Hepatitis. Washington, DC: U.S. Department of Health and Human Services; 2011.

Information & Authors

Information

Published In

cover image Annals of Internal Medicine
Annals of Internal Medicine
Volume 156Number 421 February 2012
Pages: 271 - 278

History

Published online: 21 February 2012
Published in issue: 21 February 2012

Keywords

Authors

Affiliations

Kathleen N. Ly, MPH
From the Centers for Disease Control and Prevention, Atlanta, Georgia.
Jian Xing, PhD
From the Centers for Disease Control and Prevention, Atlanta, Georgia.
R. Monina Klevens, DDS, MPH
From the Centers for Disease Control and Prevention, Atlanta, Georgia.
Ruth B. Jiles, PhD, MPH
From the Centers for Disease Control and Prevention, Atlanta, Georgia.
John W. Ward, MD
From the Centers for Disease Control and Prevention, Atlanta, Georgia.
Scott D. Holmberg, MD, MPH
From the Centers for Disease Control and Prevention, Atlanta, Georgia.
Acknowledgment: The authors thank Dr. Tara Vogt for her technical assistance early in the analysis and Drs. Richard Selik, Division of HIV/AIDS Prevention, and Deborah Holtzman, Division of Viral Hepatitis, Centers for Disease Control and Prevention, for their helpful review and suggestions for the manuscript.
Grant Support: By the Centers for Disease Control and Prevention.
Reproducible Research Statement: Study protocol and data set: Available at www.cdc.gov/nchs/data_access/Vitalstatsonline.htm. Statistical code: Available from Ms. Ly (e-mail, [email protected]) or Dr. Xing (e-mail, [email protected]).
Corresponding Author: Kathleen N. Ly, MPH, Division of Viral Hepatitis, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop G-37, Atlanta, GA 30333; e-mail, [email protected].
Current Author Addresses: Ms. Ly and Drs. Xing, Klevens, Jiles, Ward, and Holmberg: Division of Viral Hepatitis, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop G-37, Atlanta, GA 30333.
Author Contributions: Conception and design: K.N. Ly, J. Xing, R.M. Klevens, R.B. Jiles, J.W. Ward, S.D. Holmberg.
Analysis and interpretation of the data: K.N. Ly, J. Xing, S.D. Holmberg.
Drafting of the article: K.N. Ly, R.M. Klevens, J.W. Ward, S.D. Holmberg.
Critical revision of the article for important intellectual content: K.N. Ly, R.M. Klevens, J.W. Ward, S.D. Holmberg.
Final approval of the article: R.M. Klevens, R.B. Jiles, J.W. Ward, S.D. Holmberg.
Statistical expertise: J. Xing.
Obtaining of funding: R.B. Jiles, J.W. Ward, S.D. Holmberg.
Administrative, technical, or logistic support: R.B. Jiles, S.D. Holmberg.

Metrics & Citations

Metrics

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format





Download article citation data for:
Kathleen N. Ly, Jian Xing, R. Monina Klevens, et al. The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007. Ann Intern Med.2012;156:271-278. [Epub 21 February 2012]. doi:10.7326/0003-4819-156-4-201202210-00004

View More

Get Access

Login Options:
Purchase

You will be redirected to acponline.org to sign-in to Annals to complete your purchase.

Create your Free Account

You will be redirected to acponline.org to create an account that will provide access to Annals.

View options

PDF/ePub

View PDF/ePub

Related in ACP Journals

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media